Immuron Ltd Files 6-K for October 2025 Announcements
Ticker: IMRN · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, foreign-private-issuer, announcement
TL;DR
Immuron Ltd dropped a 6-K for Oct announcements, check it for updates.
AI Summary
Immuron Limited filed a Form 6-K on October 14, 2025, reporting on two public announcements made during October 2025. The company is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing provides an update on Immuron Limited's recent communications, which could contain material information relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing reporting on previous announcements, not a material event itself.
Key Players & Entities
- Immuron Limited (company) — Registrant
- October 2025 (date) — Period of announcements
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report filing
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report on two public announcements made by Immuron Limited during the month of October 2025.
Is Immuron Limited a U.S. or foreign company for SEC filing purposes?
Immuron Limited is a foreign private issuer, as indicated by its filing of Form 6-K and the checkmark next to Form 20-F for annual reports.
What is the principal executive office address of Immuron Limited?
The principal executive office of Immuron Limited is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Immuron Limited furnish information under Rule 12g3-2(b)?
No, Immuron Limited has indicated that it is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the Commission File Number for Immuron Limited?
The Commission File Number for Immuron Limited is 001-38104.
Filing Stats: 310 words · 1 min read · ~1 pages · Grade level 18.1 · Accepted 2025-10-14 07:45:37
Filing Documents
- ea0261026-6k_immuron.htm (6-K) — 12KB
- ea026102601ex99-1_immuron.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 17KB
- ex99-1_002.jpg (GRAPHIC) — 45KB
- ex99-1_003.jpg (GRAPHIC) — 21KB
- ex99-1_004.jpg (GRAPHIC) — 10KB
- 0001213900-25-098382.txt ( ) — 157KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on October 13, 2025 titled: - Immuron Q1 FY26 YoY growth A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron Q1 FY26 YoY growth 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 14, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3